Insulin pen accessory provides better diabetic management

Irish medtech company, Innovation Zed, has announced a new attachable accessory for insulin pens to allow for more flexible insulin management options for diabetic patients.

The InsulCheck Connect automatically collects and records insulin pen usage and behavior data. The acquisition of data allows better diabetes management and aims to generate more positive health outcomes.

InsulCheck Connect is the result of a three-year research and development project and builds on the company’s original InsulCheck accessory.  

John Hughes, CEO at Innovation Zed - and himself an insulin user explained, "This platform will result in a considerable step up in the performance and effectiveness for the 100+ million existing insulin pen users, enabling functions similar to pump technologies but at a significantly lower cost. We are delighted to be announcing this important development at an event where so many experts in the field are gathered.”

“Our research with the insulin pen user population, which represents well over 70% of insulin administration today, shows that compliance is significantly below what is prescribed. We firmly believe there are ways to improve this and generate better health outcomes for people with diabetes. What was lacking previously was the automatic collection of evidenced behaviour data to enable precise management of the condition. But through InsulCheck Connect that is now here” said technical director, William Cirillo.